IP Library Granted Patent US 8,858,800
Granted Patent B2
US 8,858,800 · App. 11/996,357 · Granted Oct 14, 2014

Manufacture of chromatography matrices

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,858,800
App. No.
11/996,357
Granted
Oct 14, 2014
Kind
B2
Abstract

The present invention relates to a method of manufacturing a chromatography matrix comprising providing a polysaccharide carrier comprising available hydroxyl groups; and reacting said hydroxyl groups with vinyl sulphonate to provide a sulphonate-functionalized (S-functionalized) cation exchanger. The hydroxyl groups of the carrier may be hydroxyls of the agarose polymer; or alternatively they may be provided on extenders such as polyhydroxyfunctional polymers. In one embodiment, the carrier is made of agarose with improved flow pressure properties.

Claims (12)

1. A method of manufacturing a chromatography matrix comprising

providing at least one cross-linked agarose carrier comprising available hydroxyl groups; and

reacting said hydroxyl groups with vinyl sulphonate to provide a sulphonate-functionalized (S-functionalized) cation exchanger;

wherein the hydroxyl groups are coupled to the carrier surface via extenders that comprise dextran;

further wherein the carrier is provided by:

(a) providing an aqueous agarose solution and substituting part of the hydroxyl groups of said agarose;

(b) gelling the agarose solution to provide a carrier; and

(c) cross-linking the agarose gel obtained from (b) by reacting hydroxyl groups of the agarose.

2. The method of claim 1 , wherein said substitution of hydroxyl groups as defined in (a) is provided by addition to the agarose solution of at least one bifunctional cross-linking agent having one active site and one inactive site and reacting such active sites with part of the hydroxyl groups of the agarose; wherein inactive sites of said added cross-linking agent are activated subsequent to the gelling as defined in (b); and wherein the so activated sites are reacted with hydroxyl groups of the agarose gel to provide the cross-linking as defined in (c).

3. The method of claim 1 , wherein the carrier is porous.

4. The method of claim 1 , wherein the carrier is comprised of essentially spherical gel particles.

5. The method of claim 1 , wherein the carrier is a membrane.

Assignments (3)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIOPROCESS R&D AB
To: CYTIVA BIOPROCESS R&D AB
Reel/Frame 054299/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2016
From: GE HEALTHCARE BIO-SCIENCES AB
To: GE HEALTHCARE BIOPROCESS R&D AB
Reel/Frame 038811/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 22, 2008
From: AXEN, ANDREAS; GLAD, GUNNAR; IHRE, HENRIK; LARSSON, ANDERS; NORRMAN, NILS
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 020394/0678 →